Author - Ziad

NEW STUDY: ONLY ONE QUARTER OF U.S. ADULTS WILL HAVE CABLE TV IN A FEW YEARS

Pixability, the provider of software and insights for video advertising on YouTube and other leading connected TV (CTV) platforms, today announced the release of a new study — How We Watch Now: US Consumer Streaming Habits on YouTube and Other Connected TV Platforms. The study, based on a survey of more than 700 U.S. adults over 18, examined trends in traditional and connected TV viewership, along with content consumption preferences and use of major CTV streaming platforms. While 59% of...
Read more...

ANGEL CITY FOOTBALL CLUB X ARCHER ROOSE WINES PARTNERSHIP | ARCHER ROOSE

Today, Angel City Football Club (ACFC) announced Archer Roose Wines as the team’s Official Wine Partner. The partnership with the Boston-based luxury canned wine company stemmed from a shared value of supporting and elevating female trailblazers. Through the game-changing Angel City Sponsorship Model, in which 10% of every partnership is reallocated back into the LA community, ACFC and Archer Roose will benefit programs that promote inclusivity in sport. Read more >>
Read more...

Neuraly Announces Completion of Enrollment in Phase 2 Clinical Trial of NLY01 in Patients with Parkinson’s Disease

Neuraly, a clinical stage biotechnology company pioneering disease-modifying agents for neurodegenerative disorders, today announced the completion of patient enrollment in its Phase 2 study of NLY01 for Parkinson’s disease (PD). NLY01, Neuraly’s lead development asset, is a glucagon-like peptide 1 receptor (GLP-1R) agonist that has been demonstrated to inhibit pathological activation of microglia by binding upregulated GLP-1R in animal models of neurodegenerative diseases such as PD. Read more >>
Read more...

Podcast 354: Laurel Taylor of FutureFuel.io and Sunil Sachdev of Fiserv

The guests on the Fintech One-on-One Podcast are Laurel Taylor, the CEO and founder of FutureFuel.io and Sunil Sachdev, the Head of Fintech at Fiserv. These two companies have partnered to tackle the student debt problem, by bringing tools, awareness, and scale in this unique partnership. In this podcast you will learn: How Laurel’s personal experience with student loan debt led to the founding of FutureFuel.io/Why Fiserv created a fintech group/Why it is important for Fiserv to tackle student loan...
Read more...

MoEngage Partners with Anti-Superficial Dating App S’More to Deliver Personalized Customer Engagement and Scale App Activity

S'More, the anti-superficial dating app that connects singles based on content instead of looks, has tapped insights-led customer engagement platform MoEngage to provide hyper-personalized experiences across mobile channels such as push notifications and in-app campaigns. Leveraging MoEngage's data-driven customer insights, S'More can onboard customers and then analyze, segment, and send highly personalized messages that keep them coming back to make more meaningful connections. Read more >>
Read more...

Pyramid Biosciences Announces TIME Trial™ Program Collaboration with Tempus for Patients with NTRK Fusion Solid Tumors

Pyramid Biosciences, Inc., a clinical-stage biotechnology company developing a portfolio of precision therapies targeting a range of serious diseases, today announced a collaboration with Tempus, a leader in artificial intelligence and precision medicine, to strengthen and amplify identification of potential patients with NTRK fusion-driven cancers for participation in the ongoing Phase 1/2 trial of Pyramid's lead oncology program PBI-200, a best-in-class, next-generation, highly CNS-penetrant TRK inhibitor (PBI-200-101). Read more >>
Read more...

Akston Biosciences CEO to Present at the World Vaccine Congress

Akston Biosciences Corporation, a developer of new classes of biologics, announced that its president and CEO, Todd Zion, Ph.D., has been invited to present at this year’s World Vaccine Congress (WVC). This is the largest, most prestigious meeting dedicated to vaccines and will be held on April 18-21 in Washington, DC. In addition, the company’s Fc-fusion protein platform has been shortlisted in the best new vaccine technology category of the World Vaccine Congress Vaccine Industry Excellence (ViE) Awards.
Read more...

Wasabi Technologies Partners with the Boston Red Sox Through Multi-Year Sponsorship Deal with Fenway Sports Group

Wasabi Technologies, the hot cloud storage company, today announced a multi-year partnership with Fenway Sports Group that harnesses the power of sports and entertainment to take the Wasabi brand to new heights. Wasabi is designated a Proud Partner of the Boston Red Sox, generating unprecedented brand awareness, community relations initiatives, and client and employee engagement across Fenway Sports Group properties through 2026. With headquarters in the heart of Boston, Wasabi was founded in 2017 by Carbonite founders David Friend and...
Read more...

Akston Biosciences Doses First Volunteers in Phase II/III Clinical Trial of Low Cost, Shelf Stable COVID-19 Vaccine

Akston Biosciences Corporation, a developer of new classes of biologic therapeutics, announced today that the first volunteers in a Phase II/III clinical study of AKS-452, its low cost, shelf stable protein subunit COVID-19 vaccine, were dosed in India. India’s Central Drugs Standard Control Organization (CDSCO) approved the double-blind, placebo-controlled trial, initiated by Ahmedabad-based Veeda Clinical Research Limited, whose data will be submitted in an application for Emergency Use Authorization (EUA). The multicenter trial will complete the enrollment of 1,500 healthy...
Read more...